Your browser doesn't support javascript.
loading
Novel-and Not So Novel-Inhibitors of the Multifunctional CRM1 Protein.
Aumann, Waitman K; Kazi, Rafi; Harrington, Amanda M; Wechsler, Daniel S.
Afiliação
  • Aumann WK; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, United States.
  • Kazi R; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.
  • Harrington AM; Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Rochester Medical Center, Rochester, NY, United States.
  • Wechsler DS; Department of Pediatrics, University of Kentucky College of Medicine, Lexington, KY, United States.
Oncol Rev ; 18: 1427497, 2024.
Article em En | MEDLINE | ID: mdl-39161560
ABSTRACT
Chromosome Region Maintenance 1 (CRM1), also known as Exportin 1 (XPO1), is a protein that is critical for transport of proteins and RNA to the cytoplasm through the nuclear pore complex. CRM1 inhibition with small molecule inhibitors is currently being studied in many cancers, including leukemias, solid organ malignancies and brain tumors. We review the structure of CRM1, its role in nuclear export, the current availability of CRM1 inhibitors, and the role of CRM1 in a number of distinct cellular processes. A deeper understanding of how CRM1 functions in nuclear export as well as other cellular processes may allow for the development of additional novel CRM1 inhibitors.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncol Rev Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncol Rev Ano de publicação: 2024 Tipo de documento: Article